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STRUCTURED ABSTRACT
Background and objectives: Young adults receiving renal replacement therapy (RRT) face additional challenges in life. The impact of established kidney failure on young adulthood is uncertain. We aimed to establish the psychosocial and lifestyle status of young adults receiving RRT.
Design, setting, participants, and measurements: Systematic review and meta-analysis of [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] year olds receiving RRT, compared with the general population. We selected randomized controlled trials, cohort or cross-sectional studies without language restriction and extracted proportions of socio-demographic and lifestyle outcomes; or validated psychological health tests producing quality of life, wellbeing and self-esteem scores. We undertook randomeffects meta-analysis.
Results: 60 studies of 15575 participants. Studies were largely single center cross-sectional studies of those transplanted in childhood. Compared to healthy peers, young adults on RRT had lower quality of life, worse for dialysis patients (7 studies, standardized mean difference (SMD) -1.01, 95% confidence interval (CI) -1.32, -0.70) compared to transplant (9 studies, SMD -0.42, 95% CI -0.64, -0.20). They were more likely to be unemployed (7 studies, relative risk (RR) 1.89, 95% CI 1. 47, 2.44) and to live in the family home (2 studies, RR 1.84, 95% CI 1.40, 2.43). They were less likely to be married or have a partner (4 studies, RR 0.71, 95% CI 0.53, 0.95). Higher education (3 studies, RR 1.05, 95% CI 0.73, 1.51), alcohol abstinence (3 studies, RR 1.96, 95% CI 0.84, 4.67) and smoking status (2 studies, RR 0.72, 95% CI 0.36, 1.44) did not differ. Results were limited by high heterogeneity and a small evidence base, biased towards surviving patients.
Conclusions: Established kidney failure is associated with lower quality of life in young people and limited employment, independence and relationships compared with healthy peers.
INTRODUCTION
Young adulthood is a distinct developmental period where physical growth stops yet highlevel brain function continues to develop (1) . Young adulthood features growing independence, decision-making, self-exploration and experimentation. Young adults receiving renal replacement therapy (RRT) in high-income countries are mostly transplanted (70% of United States 0-21 year olds(2) and 73% of United year olds(3)) and must learn to integrate responsibility for managing their condition into their changing lives.
There are little data regarding psychosocial outcomes for young adults, an area not captured by most disease registers. Whilst young adults are known to be high risk for graft failure (4, 5) , the extent to which established kidney failure has affected their social status, mental health and lifestyle remains unclear. The literature to date focuses on single center cohorts of transplanted children followed to young adulthood, and the process of transition to adult services (6, 7) . Those receiving dialysis, presenting directly to adult services and nonsurviving patients are underrepresented.
We aimed to review the literature systematically to establish the socio-demographic, psychological health and lifestyle status of young adults receiving RRT. This information is important to determine whether patients lead comparable lives to their healthy peers. We hypothesized that young adults receiving RRT would be psychosocially disadvantaged compared to healthy peers.
MATERIALS AND METHODS
We conducted this systematic review in accordance with Meta-analysis of Observational Studies in Epidemiology (MOOSE) criteria (8) rather than Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA), as it is more appropriate for observational studies. We did not use a review protocol.
Eligibility Criteria
We used the criteria defined in Table 1 to select studies from our systematic search. We included all studies reporting socio-demographic, psychological health and lifestyle outcomes for young adults (defined as aged between 16 and 30 years at the time of study) receiving long-term RRT. There is no consensual definition for young adulthood, and we chose a wide age-range to ensure we did not miss any important publications. We included all language types.
Search Strategy
Together with an Information Specialist, we devised a sensitive search strategy (supplementary material) which we applied to 9 databases (Medline, EMBASE, PsycINFO, Applied Social Sciences Index and Abstracts (ProQuest), CINAHL (EBSCO), Web of Science, Scopus, Open Grey, and Cochrane Library). We ran our first search in July 2015 and repeated the search in August 2016, for the latter limiting results to those from the last year only. We also screened references of key articles obtained in our search.
Where studies did not present appropriate data (e.g. subgroup data not presented, or study published in abstract form), we asked authors by email for the data if the study was carried out in the last five years; 2/5 study authors responded to these requests.
Study Selection, Data Collection, and Risk-of-Bias Appraisal
We imported all references into Endnote™ and then used this software to remove duplicate publications. AH screened the titles and abstracts of all citations to identify studies fulfilling the inclusion criteria. RC screened a random sample of 1000 titles and abstracts to ensure consistency. Concordance was 99% and any disagreements were resolved by discussion. We used Google Translate™ to screen non-English abstracts and arranged formal translation of included non-English articles.
Where there were multiple versions of the same study, we selected the more comprehensive/substantive version (e.g. journal article over conference abstract, or journal articles arising from theses). We recorded study characteristics and used the Newcastle-Ottawa Scale (NOS) to assess the risk of bias for all studies (9) . A high NOS score (range 0 -9) indicates a lower risk of bias. AH assessed bias in all included studies. RC independently assessed bias in a random sample of six (10%) of the included studies to ensure a fair appraisal. Any disagreements were resolved by discussion.
Summary Measures and Synthesis of Results
We examined studies fulfilling the inclusion criteria and collated whether studies reported common outcome measures (regardless of scales used) before deciding on which outcome measures were amenable to meta-analysis. If a study presented multiple scales for a single outcome, we chose the most frequently used scale for analysis. We compared the data across studies and devised a data collection form to obtain consistently reported data. Study review and data extraction was performed by AH. RC independently extracted data from a random sample of six (10%) of the included studies to ensure consistency and accuracy. There was 100% concordance for data extraction.
Statistical Methods and Subgroup Analysis
For outcomes reported as proportions, we extracted these and calculated their 95% confidence intervals (CI) by assuming a binomial distribution using Wilson's method (10) as no study reported these. We then performed a meta-analysis of the outcome proportion using a random effects model (employing DerSimonian & Laird's method), as we presumed there would be marked between-study heterogeneity given methodological differences. We visually examined effect estimates using forest plots and calculated heterogeneity statistics (I 2 and 95% CI using a non-central χ 2 based approach(11), τ 2 ). We did not stratify by modality at enrolment as most studies were long-term follow-ups of pediatric kidney transplant patients where current modality was not reported, or the outcome proportion by modality was not provided. However, most studies reporting quality of life scale scores did so by modality so one could compare sub-groups.
For studies with control data, papers reported a proportion/percentage outcome and sample size for the kidney sample and provided comparative control data mostly using census/routine survey data (no reported sample size in seven cases; number with outcome/total in three cases and the number with outcome/no total in one case). We converted outcome rates (95% CI) for the kidney sample as above. The statistics comparing the kidney sample to controls were limited; there was no comparison in six studies, the Chi-Square test in two studies, p-value only in two studies and a standardized incidence ratio and p-value in one study. Therefore where the reference sample size was unknown (n=8), we calculated the risk ratio (RR) (95% CI) by dividing study group risk by control group risk. This assumed no sampling variation for the larger reference population, as these are based on much larger samples and assume all the variability in the RR is determined by the sampling variability in the smaller clinical group. Our calculated RR matched the standardized incidence ratio where provided. Where the sample size was known (n=3), we accounted for reference population variability. We then inspected forest plots (log RR) and chose to undertake a random effects meta-analysis (as above) to derive the pooled RR (95% CI, I 2 statistic and 95% CI, τ 2 ).
Quality of life is often assessed using the SF-36 measure, which has four physical and four mental domains, or the EQ-5D, which weights five domains (anxiety, pain, mobility, usual activities, self-care) to produce a utility score with a maximum of 100. To summarize the quality of life data to a single domain or utility score, we converted mean SF-36 domains to an overall utility score using a model (EQ1) developed by Ara and Brazier(12) , regarded as the best approach in the absence of individual participant level data. This model was derived using ordinary least square regression models and weights each SF-36 domain to derive an EQ-5D utility score, as follows:
EQ-5D utility score = 0.03256 + (0.0037*physical functioning) + (0.0011*social function) - We confirmed the validity of this model by showing similar model-derived SDs and reported SDs in our extracted data. Because the utility score is numerical, we performed a random effects meta-analysis using Glass' method (which standardizes using the reference group SD) to pool standardized mean differences (SMD) using the mean scale score, SD and sample size for patient and control groups stratified by modality. We also used this approach for the non-SF-36 quality of life scales. We derived both the overall heterogeneity statistics (I 2 and 95% CI, τ 2 ) as well as assessing for subgroup (transplant versus dialysis) heterogeneity to test for an interaction. If studies did not report a normative comparator, we still included them in the meta-analysis if we were able to find appropriate country and age-specific control data (mean, SDs). We undertook several sensitivity analyses. We repeated the meta-analysis excluding the studies with derived control data to see if this altered our results qualitatively.
We also performed separate meta-analyses by modality. Stratifying by modality in some cases meant including two subgroups from the same study. This does not affect the point estimate as the data points were independent, but because the two subgroups come from the same study there is the potential for structural clustering, so that the standard errors for the pooled modality estimates may be underestimated. We investigated this by repeating the meta-analysis by modality but this time meta-analyzing the treatment-by-modality interaction in studies that reported data for both transplant and dialysis patients. We assessed for small study effects using funnel plots, comparing by modality and excluding studies that did not report normative comparators (to avoid artificially inflating the effect estimate sample size).
To help the reader contextualize the SMD results, we used normative data from the 2012 Health Survey for England (14) and back-calculated the differences in the SMD for the kidney patients to an absolute EQ-5D utility using the reported SD.
For studies reporting other scale scores, we performed a random effects meta-analysis using the same methods as for the utility score analysis. We used Stata® 14 for our analyses.
RESULTS

Description of included studies
We included 60 studies in our quantitative review. We identified seven qualitative studies, which are not discussed further. Figure 1 demonstrates the results of our systematic searches, and table 2 details the characteristics of the included studies. Table 3 summarizes the study attributes, and highlights that most studies were small (median 42 participants, interquartile range (IQR) 25, 78), single center (75%), and cross-sectional (80%). Half the studies examined young people transplanted in childhood. Studies were mainly from high-income countries (78%). Where reported, the recruitment, response rate and key variable completeness of the various study types was reasonably high. However, the response rate was not reported in two-thirds of surveys.
Risk of bias
The modified NOS scores are shown in Table 3 . The risk of bias was higher in studies that did not report any normative comparator data. The overall scale median percentage score was 71% (IQR 50, 75). Since 80% of our identified publications were cross-sectional, they are subject to attrition bias, as patients who may have died over follow-up are by definition not included and hence the observed results may be biased towards better outcomes. Two-thirds of studies involved surveys and/or interviews, where engaged patients are more likely to take part (selection bias). In addition, given the subjective nature of many of the outcomes, there may be recall and interviewer bias. Two-thirds of studies involved transplant patients; half the studies only recruited participants on the basis that they were transplanted as children, so that young adults presenting later may be underrepresented. Most studies were European/North American, reflecting a geographical bias towards these healthcare systems.
Three-quarters of studies involved convenience sampling from single centers; here, center performance and clinician motivation may also bias results.
Observed proportions
The pooled proportion estimates for socio-demographic, psychological health and lifestyle outcomes are shown in table 4. Socio-demographic outcomes were commonly reported.
There was considerable heterogeneity which was unaffected by stratifying by modality at enrolment.
There were fewer studies examining psychological health, with depression or anxiety being most frequently reported, although there was marked heterogeneity. Most of the data were pooled from three studies that studied transplant patients using the same questionnaire (15) (16) (17) , and apart from depression/anxiety and body image, all the estimates were from studies examining transplant patients. The apparent disparity between suboptimal mental health and good satisfaction in other areas of life may be explained by the small number of studies, and patient modality.
In terms of lifestyle, there were again few studies and high heterogeneity for the proportions of those currently smoking, taking part in sports and abstaining from alcohol. Young adults appeared to live healthy lifestyles.
Outcomes relative to healthy controls
The pooled effect estimates of socio-demographic, psychological health and lifestyle outcomes compared to healthy controls are shown in table 5. Few studies presented normative comparison data and, when pooled, were very heterogeneous.
Young adults on RRT were more likely to be unemployed (8 studies, RR 1.89, 95% CI 1.47, 2.44) and to live in the family home (2 studies, RR 1.84, 95% CI 1.40, 2.43). They were less likely to be married/have a partner (4 studies, RR 0.71, 95% CI 0.53, 0.95). Higher education (3 studies, RR 1.05, 95% CI 0.73, 1.51), alcohol abstinence (3 studies, RR 1.96, 95% CI 0.84, 4.67) and smoking status (2 studies, RR 0.72, 95% CI 0.36, 1.44) did not differ.
Psychological health scales
Only 5/9 studies measuring quality of life in transplant patients reported normative comparison data, and similarly only 3/7 studies in dialysis patients (table 5 ). The study sample sizes were small, particularly for dialysis patients (median n=17). Heterogeneity was less when stratifying by modality but remained high. The SF-36 was the most frequently used scale (n=4). Seven studies reported relevant quality of life measures, which we could not include in the meta-analysis due to missing variability data (n=3) or control data (n=4).
Young adults on RRT had lower quality of life compared to their peers, which was worse for dialysis patients (7 studies, SMD -1.01, 95% CI -1.32, -0.70) compared to transplant (9 studies, SMD -0.42, 95% CI -0.64, -0.20) (figure 2). This equates to the following absolute differences in EQ-5D utilities: mean utility for 16 table 5 footnote for data). We found no evidence for small study effects (p=0.7) but analysis lacked power as few studies were available for inclusion.
We found no differences in the Positive and Negative Affect Schedule (PANAS), and the Rosenberg Self-Image Scale and Self-Perception Profile for Adolescents though these were measured in few studies with small numbers of participants and subject to high heterogeneity.
Five studies reported relevant self-concept, self-esteem or self-image scale measures, which we could not include in the meta-analysis due to missing information (n=2) or a lack of control data (n=3). Three studies reported coping via the use of different multi-domain scales and could not be combined in a meta-analysis.
DISCUSSION
Key findings
This systematic review establishes the negative social and psychological impacts (lower quality of life and limited employment, independence and relationships) of end-stage renal disease (ESRD) on young adults compared to healthy controls and highlights the limitations of existing research. We have found a marked drop in quality of life particularly for dialysis patients compared to those transplanted. Young adults on RRT were also more likely to be unemployed despite a similar proportion having higher education as in the general population (based on only three studies). The effect estimates we present are likely to be biased towards better outcomes, as many studies examined transplant patients and may be subject to a healthy responder bias.
Comparison with existing studies
To our knowledge, this is the first quantitative systematic review of psychosocial and lifestyle outcomes for young adult RRT patients. We found a similar drop in quality of life for dialysis compared to transplant as a previous systematic review in an older adult population (13), however comparison is limited as we calculated a Z-score relative to the general population, whereas Wyld et al reported absolute utility scores.
Implications for research and clinical care
This meta-analysis has identified some areas of concern regarding the long-term sociodemographic and psychological outcomes for young adults with ESRD. However, one must be cautious in interpreting these results given the limitations highlighted below. These data, despite a small evidence base, suggests limited life chances and need further attention to establish how young adults receiving RRT function in society and potential barriers they may face to establishing successful employment, independent living and long-term relationships.
It is possible that psychosocial outcomes may be more meaningful to patients than biochemical and intermediate outcomes often collected by registries. In the short term, we are undertaking a large-scale national multi-center study looking at a young adult population of all treatment modalities: the Surveying People Experiencing young Adult Kidney failure (SPEAK) study (18) . The results may raise awareness in the clinical setting and shift the focus of outcomes onto those that matter most to patients, perhaps prompting disease registers to collect patient-centered outcomes. Ideally, researchers should undertake a large, prospective cohort study collecting baseline data in childhood and with repeat outcome measure data that span the transition into adulthood as well as later life. Comparative longitudinal population data, using the same methods, should also be available to facilitate interpretation. Such a study would be costly, challenging and would take at least a decade to undertake but would provide a far more robust evidence base on the needs of this ESRD population.
Strengths and limitations
The strengths of this review are the wide search criteria to ensure all relevant studies were included, the inclusion of grey literature and non-English articles, and repeating the systematic search to capture new studies. Furthermore, we have gone to great lengths not to lose valuable data by contacting authors for other data, converting different outcomes to a common metric and searching appropriate comparative data to provide additional measures of outcome differences.
There are also limitations to be consider. Firstly, the evidence base was small. Secondly, in some cases we had to assume no sampling variation in reference populations of unreported size. This results in artificially small CIs around the difference. Nonetheless, in all cases where this assumption was made, the normative data was based on census data or regional/national statistics, so this is a minor issue. Thirdly, pooled proportions come from different studies and therefore may not always be directly comparable due to reporting differences. Fourthly, we combined mean domain scores into a single EQ-5D utility score for the SF-36 quality of life studies. Although we used established methods for this conversion and calculating the score variability, these were validated in other datasets; however, where data were available the predicted values appeared consistent with the observed. Fifthly, many studies did not report sub-groups data, such as gender and modality (except for quality of life), so we could not examine these variables for heterogeneity. Given the paucity of studies, we did not feel that exploration of between-study variability using meta-regression would have been helpful; in addition, we were reassured that subgroups were statistically (but not structurally) independent when including subgroups as individual studies in meta-analysis.
Finally, as there were almost 20,000 abstracts to screen, we only checked a random sample of 1000 abstracts (5%) for inclusion and six studies (10%) for independent data extraction though concordance rates were high in both cases.
Quantitative assessment of bias
The nature of the studies in this area was such that we could only quantitate bias by modifying the NOS. For studies without comparator data, this lessened the scope of the bias assessment and the risk of bias was higher. However overall study quality appeared reasonable. In addition to the NOS, we summarized the study attributes in table 3 and described the potential bias that these attributes suggest.
Justification of exclusion
We excluded studies where outcomes were reported by caregiver/family/health or educational professionals to focus on the patient experience, particularly from a psychological perspective. Other reasons that studies were excluded are included in figure 1 -largely due to the reported average age of participants being outside the specified range.
Assessment of quality of included studies
The Oxford Centre for Evidence-based Medicine (19) grades evidence from level 1a (e.g. homogenous systematic review) to 5 (e.g. expert opinion without critical appraisal), and grades recommendations based on such evidence from level A (consistent level 1 studies) to D (inconsistent/inconclusive or level 5 evidence). According to this framework, overall the studies in this review are from level of evidence 2b to 4 and grade of recommendation B/C. In general, studies were descriptive, cross-sectional and single center with small numbers of participants. There were no prospective studies though three studies were retrospective cohort studies. Whilst a third of studies presented normative data, these almost all used data collected for other purposes.
Generalization of the conclusions
Our review included young adults requiring RRT, and studies appropriately focused on transplant patients as they represent much of this age group in high-income countries where the studies were mostly undertaken. Therefore, the effect estimates we have presented are generalizable to transplant patients in high-income countries, but apart from quality of life may not be generalizable to young adults receiving dialysis. The small number of studies and high heterogeneity of findings must also be stressed, as well as the inability to explore demographic effects.
In summary, young adults receiving RRT have lower quality of life and limited employment, independence and relationships compared to healthy controls. This review highlights the limitations of existing research and clarifies the key patient-reported outcomes to focus on in the future.
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Psychological health
Depression/anxiety 449 13 0.30 (0.20, 0.40) 88 (82, 92) 0.03 (15, 17, 29, 32, 38, 42-45, 48, 54, 56, 67) Self-rated health excellent or good 243 6 0.85 (0.76, 0.93) 74 (16, 87) 0.008 (15-17, 29, 45, 50) Dissatisfied with body image 314 5 0.30 (0.16, 0.44) 88 (71, 93) 0.02 (15, 27, 29, 30, 37) Satisfied with life 151 3 0.88 (0.83, 0.93) 0 (0, 73) <0.001 (15) (16) (17) Normal health, no complaints 151 3 0.55 (0.42, 0.68) 59 (0, 86) 0.007 (15) (16) (17) Satisfied with personal relationships 151 3 0.76 (0.56, 0.96) 89 (61, 95) 0.03 (15) (16) (17) Health never/seldom affects social life 151 3 0.72 (0.53, 0.92) 86 (38, 94) 0.02 (15) (16) (17) Family support Satisfied with family support 300 6 0.79 (0.69, 0.89) 81 (53, 90) 0.01 (15-17, 52, 56, 67) Disease never/seldom affects family life 151 3 0.80 (0.51, 1.08) 96 (93, 98) 0.06 (15) (16) (17) 
Sexual function
Satisfied with sex life 178 4 0.53 (0.30, 0.77) 92 (82, 95) 0.05 (15) (16) (17) 29) Health no obstacle to sex life 120 2 0.46 (0.37, 0.54) 0 <0.001 (15, 17) Lifestyle (17, 30, 35, 76) Sees friends or relatives at least weekly 176 4 0.84 (0.78, 0.91) 27 (0, 76) 0.001 (15) (16) (17) 76) Abstains from alcohol 536 3 0.30 (0.03, 0.57) 98 (97, 99) 0.05 (30, 36, 38) Has a driving license 501 3 0.65 (0.61, 0.69) 0 (0, 73) <0.001 (25, 36, 64) Attends social events at least weekly 134 2 0.56 (0.43, 0.70) 64 0.006 (15, 17) CIconfidence interval *CI for I 2 incalculable with one degree of freedom. 
